Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Klaria Pharma Holding

0.82 SEK

-1.69 %

Less than 1K followers

KLAR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Klaria Pharma Holding

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)3.975.675.641.130.450.330.67
Shares34.156.756.780.4109.3148.5246.0
Market cap135.2321.2319.790.949.248.5163.8
Enterprise value132.3290.0294.2----
EV/S31.3------
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B1.652.934.611.201.2014.65-42.23
P/S32.0--15.5-21.618.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio80.7 %82.8 %58.7 %63.3 %56.3 %5.8 %-9.5 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.